CS268633B1 - Process for the preparation of 6- (diethylaminoalkoxy) - 10,11-dihydrodibenzo / b, f / thiepin-10-ol and their maleates - Google Patents
Process for the preparation of 6- (diethylaminoalkoxy) - 10,11-dihydrodibenzo / b, f / thiepin-10-ol and their maleates Download PDFInfo
- Publication number
- CS268633B1 CS268633B1 CS886945A CS694588A CS268633B1 CS 268633 B1 CS268633 B1 CS 268633B1 CS 886945 A CS886945 A CS 886945A CS 694588 A CS694588 A CS 694588A CS 268633 B1 CS268633 B1 CS 268633B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- thiepin
- dihydrodibenzo
- maleates
- preparation
- dimethylaminopropoxy
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
ŘeSení spadá do oboru synthesy léčiv. Jeho předmětem je způsob přípravy 6-(2-dimethylaminoethoxy)- a 6-(3-dimethylaminopropoxy)-iO,11-dihydrodibenzo/b,f/thiepin-10-olu a jejich maleinátú. Tyto látky jsou jednak meziprodukty synthesy farmakódynamicky účinných sloučenin, jednak samy o sobě projevují centrálně tlumivou (trankvilizační) účinnost. Způsob jejioh přípravy spočívá v redukci 6-(2-dimethylaminoethoxy)- a 6-(3-dimethylaminopropoxy)dibenzo/b,f/- thiepin-10(l1H)-onu hydridem sodnobori— tým ve vodném ethanolu a v případě potřeby následující neutralisací získaných basí kyselinou maleinovou.The solution falls into the field of drug synthesis. Its subject is a method for preparing 6-(2-dimethylaminoethoxy)- and 6-(3-dimethylaminopropoxy)-10,11-dihydrodibenzo/b,f/thiepin-10-ol and their maleates. These substances are both intermediates in the synthesis of pharmacodynamically active compounds and, on the other hand, they themselves exhibit centrally depressant (tranquilizing) activity. The method for their preparation consists in the reduction of 6-(2-dimethylaminoethoxy)- and 6-(3-dimethylaminopropoxy)dibenzo/b,f/-thiepin-10(11H)-one with sodium borohydride in aqueous ethanol and, if necessary, subsequent neutralization of the obtained bases with maleic acid.
Description
Vynález se týká způsobu přípravy 6-(ddjnethylaminoalkoxy)-10,11-dihydrodlbonzo/b,f/thiepin-10-olů obecného vzorce IThe invention relates to a process for the preparation of 6- (dimethylaminoalkoxy) -10,11-dihydrodylbenzo [b, f] thiepin-10-ol of the general formula I
ve kterém n značí 2 nebo 3, a jejioh maleinátů.in which n is 2 or 3, and its maleates.
Látky podle vynálezu obeonáho vzorce I jsou v prvé řadě meziprodukty přípravy farmakodynamicky účinných látek a kromě toho samy o sobě vykazují některé užitečné biologické vlastnosti. Působí např. centrálně tlumívě.The compounds of the formula I according to the invention are primarily intermediates for the preparation of pharmacodynamically active substances and, in addition, themselves have some useful biological properties. It acts, for example, centrally damping.
Konkrétní biologické výsledky dosažené s látkami podle vynálezu:Specific biological results obtained with the substances according to the invention:
6-(2-Dimethylaminoethoxy)-10, 11 -dihydrodibenzo/b,f/thiepin-10-ol byl testován ve formě hydrogenmaleinátu. Jeho akutní toxicita u myáí při intravenosním podání, LD^q = s 27,5 mg/kg. V testu rotující tyčky u myěí vyvolává ataxii, což naznačuje tlumivé působení; Εϋ^θ 3 5 «7 ί·ν·6- (2-Dimethylaminoethoxy) -10,11-dihydrodibenzo [b, f] thiepin-10-ol was tested as the hydrogen maleate. Its acute toxicity in mice after intravenous administration, LD 50 = 27.5 mg / kg. In the rotating rod test in mice, it induces ataxia, suggesting a damping effect; Εϋ ^ θ 3 5 «7 ί · ν ·
6-(3-Dimethylaminopropoxy)-10,11-dihydrodibenzo/b,f/thiepin-10-ol byl rovněž ve formě hydrogenmaleinátu. Jeho akutní toxicita, LD^O = 18,9 mg/kg účinnost v testu rotující tyčky, ED^0 = 7,2 mg/kg i.v.6- (3-Dimethylaminopropoxy) -10,11-dihydrodibenzo [b, f] thiepin-10-ol was also in the form of hydrogen maleate. Its acute toxicity, LD ^ O = 18.9 mg / kg efficacy in the rotating rod test, ED ^ 0 = 7.2 mg / kg iv
Způsob přípravy látek obecného vzorce I podle tohoto vynálezu spočívá tonů obecného vzorce II centrálně testován v redukci ke(II), ve kterém n značí totéž Jako ve vzorci I, hydridem sodnoboritým ve vodném ethanolu. Výchozí ketony obecného vzorce II nebyly zatím v literatuře popsány a jejioh příprava Je proto uvedena v příkladech. Připravené látky -obecného vzorce I jsou basické povahy a Jejich neutraliaaoí kyselinou male lnovou se podle vynálezu získají krystalické hydrogenmaleináty. Všechny látky ve vynálezu popsané jsou nové a jejioh identita byla zajištěna analytickými a spektrálními metodami. Příklady představují pouze ilustraci možností vynálezu a není Jejioh úkolem všechny tyto možnosti popisovat.The process for the preparation of the compounds of the formula I according to the invention consists in the tons of the formula II centrally tested in the reduction to (II), in which n is the same as in the formula I, with sodium borohydride in aqueous ethanol. The starting ketones of the formula II have not yet been described in the literature and their preparation is therefore given in the examples. The compounds of the formula I prepared are basic in nature and crystalline hydrogen maleatates are obtained according to the invention by neutralizing them with maleic acid. All substances described in the invention are novel and their identity has been ensured by analytical and spectral methods. The examples are merely illustrative of the possibilities of the invention and it is not intended to describe all of these possibilities.
Přiklad 1Example 1
6-(2-Dimethylaniinoethoxy)-10,11-dihydrodibenzo/b,f/thiepin-10—ol (i, n s 2)6- (2-Dimethylaninoethoxy) -10,11-dihydrodibenzo [b, f] thiepin-10-ol (i, n s 2)
K míchanému roztoku 6,5 g 6-(2-dimethylaminoothoxy)dibenzo/b,f/thiepin-10(l 1H)~onu v 70 ml ethanolu se po kapkách přidá roztok 2,0 g hydridu sodnoboritého ve 20 ml vody obsahující 0,5 ml lOJí rozteku hydroxidu sodného. Směs ea vaří 'i, 5 h pod zpětným chladlSem. Těkavé podíly se odpaří ve vakuu, zbytek ee rozdílí maži vodu a benzen, benzenový roztok ee vysuší a odpaří. Získá ae 5,9 g (90 >) žádaného autového produktu, který ae vyčistí»kryataliaací z ethanolu, t.t, 12J až T25 °C*‘Neutralisaoí kyaeliaotl taolelnovou v ethánolu poakytuje krystalický hyúrogenmaleinát, t.t, 157 až 159 °C (etlianol).To a stirred solution of 6.5 g of 6- (2-dimethylaminoothoxy) dibenzo [b, f] thiepin-10 (1H) -one in 70 ml of ethanol is added dropwise a solution of 2.0 g of sodium borohydride in 20 ml of water containing 0 , 5 ml of a solution of sodium hydroxide. The mixture was refluxed for 5 h. The volatiles were evaporated in vacuo, the residue ee partitioned between water and benzene, the benzene solution ee dried and evaporated. 5.9 g (90%) of the desired automotive product are obtained, which is purified by crystallization from ethanol, m.p. 12 DEG-T25 DEG C. .
CS 268 633 B1CS 268 633 B1
Výchozí 6-(2-dimethylaminoethoxy)dibenzo/b,f/thiepin-l0(l 1H)-on, který zatím nebyl v literatuře popsán, se připraví tímto způsobem;The starting 6- (2-dimethylaminoethoxy) dibenzo [b, f] thiepin-10 (1H) -one, which has not yet been described in the literature, is prepared in this way;
K roztoku ethoxidu sodnóho, připraveného ze 3,0 6 sodíku a 350 ml ethanolu, se přidá 12,12 g 6-hydroxydibenzo/b,f/thiepin~l0(11H)-onu (Protiva M, et al,, Collect.Czech, p-hem,Pcmrmm, 40, 2667 (1975)) a 10,8 g hydroohloridů 2-dimethylaminoethylchloridu a směs se míchá a vaří 9 h pod zpětným chladičem. Po stání pres noc se vyloučený chlorid sodný odsaje, filtrát se slabě okyselí zředěnou kyselinou chlorovodíkovou a odpaří se ve vakuu, Zbytek se rozpustí ve vodě, roztok se promyje benzenem, zalkalisuje se vodným amoniakem a žádaná base se isoluje extrakcí benzenem) 10,4 g (66 ¢) olejovité base, která krystalisujo z oyklohexanu a v čistém stavu taje při 69 až 71 °C. Lze ji charaktorisovat provedením na krystalický hydroohlorid, t.t. 176 až 179 °C.To a solution of sodium ethoxide prepared from 3.06 sodium and 350 ml ethanol was added 12.12 g of 6-hydroxydibenzo [b, f] thiepin-10 (11H) -one (Protiva M, et al., Collect. , p-hem, Pcmrmm, 40, 2667 (1975)) and 10.8 g of 2-dimethylaminoethyl chloride hydrochloride, and the mixture was stirred and refluxed for 9 hours. After standing overnight, the precipitated sodium chloride is filtered off with suction, the filtrate is slightly acidified with dilute hydrochloric acid and evaporated in vacuo. The residue is dissolved in water, washed with benzene, basified with aqueous ammonia and (66%) an oily base which crystallizes from cyclohexane and melts in pure form at 69-71 ° C. It can be characterized by conversion to crystalline hydrochloride, m.p. 176-179 ° C.
Příklad 2Example 2
6-(3-Dimethylaminopropoxy)-10,11-dihydrodibenzo/b,f/thiepin-10-ol (I, n = 3)6- (3-Dimethylaminopropoxy) -10,11-dihydrodibenzo [b, f] thiepin-10-ol (I, n = 3)
Podobně jako v předchozím příkladu se redukuje 6,6 g 6-(3“dimethylaminbpropoxy)dibenzo/b,ř/thiepin-10( 11H)-onu pomocí 2,0 g hydridu sodnoboritého ve směsi 50 ml ethanolu, 20 ml benzenu a 20 ml vody. Získá se 4,8 g (73 %) surového žádaného produktu, který se vyčistí krystalisací z methanolu, t.t, 166 až 169 °C.As in the previous example, 6.6 g of 6- (3 "dimethylaminopropoxy) dibenzo [b, b] thiepin-10 (11H) -one are reduced with 2.0 g of sodium borohydride in a mixture of 50 ml of ethanol, 20 ml of benzene and 20 ml of benzene. ml of water. 4.8 g (73%) of crude desired product are obtained, which is purified by crystallization from methanol, m.p. 166 DEG-169 DEG.
Potřebný výchozí 6-(3-dimethylaminopropoxy)dibenzo/b,f/thiepin-10(11H)-on se připraví podobným způsobem, jak je to popsáno pro nižěí homolog v příkladu 1, reakcí 6,7 6 6-hydroxydibenzo/b,f/thiepin-10(11H)-onu (citace uvedena) s 6,6 g hydroohloridů 3-dimethylaminopropylchloridu v roztoku ethoxidu sodného (1,73 B sodíku, 200 ml ethanolu) (var po dobu 10 h pod zpětným chladičem). Takto se získá 6,4 g (71 %) olejovité, avěak téměř homogenní látky, která se v tomte stavu použije dále. Pro charakterisaci ji lze převést na krystalický hydroohlorid, t.t, 181 až 183 °C (ethanol-ether),The required starting 6- (3-dimethylaminopropoxy) dibenzo [b, f] thiepin-10 (11H) -one was prepared in a similar manner as described for the lower homologue in Example 1, by reacting 6.7 6 6-hydroxydibenzo [b, f / thiepin-10 (11H) -one (cited) with 6.6 g of 3-dimethylaminopropyl chloride hydrochlorides in sodium ethoxide solution (1.73 B sodium, 200 ml ethanol) (reflux for 10 h). 6.4 g (71%) of an oily, albeit almost homogeneous substance are thus obtained, which is used without further purification in this state. For characterization, it can be converted into crystalline hydrochloride, m.p. 181-183 ° C (ethanol-ether),
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS886945A CS268633B1 (en) | 1988-10-20 | 1988-10-20 | Process for the preparation of 6- (diethylaminoalkoxy) - 10,11-dihydrodibenzo / b, f / thiepin-10-ol and their maleates |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS886945A CS268633B1 (en) | 1988-10-20 | 1988-10-20 | Process for the preparation of 6- (diethylaminoalkoxy) - 10,11-dihydrodibenzo / b, f / thiepin-10-ol and their maleates |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CS694588A1 CS694588A1 (en) | 1989-08-14 |
| CS268633B1 true CS268633B1 (en) | 1990-03-14 |
Family
ID=5417635
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS886945A CS268633B1 (en) | 1988-10-20 | 1988-10-20 | Process for the preparation of 6- (diethylaminoalkoxy) - 10,11-dihydrodibenzo / b, f / thiepin-10-ol and their maleates |
Country Status (1)
| Country | Link |
|---|---|
| CS (1) | CS268633B1 (en) |
-
1988
- 1988-10-20 CS CS886945A patent/CS268633B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CS694588A1 (en) | 1989-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0005528B1 (en) | Imidazole derivatives, their preparation and pharmaceutical compositions | |
| CN106518841B (en) | Cyclohexane derivant or its stereoisomer or salt and its preparation and application | |
| CA2295792C (en) | A crystalline dibenzothiazepine derivative and its use as an antipsychotic agent | |
| US3399201A (en) | Aminoalkyl-ethano-anthracenes | |
| GB2036010A (en) | 4-((3,4-dialkoxyhenyl)-alkyl)-2-imidazolidinone derivatives and processes for the preparation thereof | |
| EP0058341B1 (en) | Azepine derivatives, their preparation and medicaments containing them | |
| FI71144C (en) | EXAMINATION OF THERAPEUTIC ACTIVATING ACTIVATED 1-EECL-6-FLUORO-1,4-DIHYDRO-4-OXO- (1-PIPERAZINYL) -1,8-NAPHTHYRIDINE-3-CARBOXYL SYRASE | |
| EP1194415B1 (en) | Novel piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same, and a process for their preparation | |
| HU228204B1 (en) | New process for the preparation of 11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]thiazepine and use thereof for the synthesis of tianeptine | |
| US3071587A (en) | Cyanoethyl-pteridines | |
| KR100372312B1 (en) | Novel hydroximic acid derivatives, pharmaceutical compositions containing them and process for preparing same | |
| CS268633B1 (en) | Process for the preparation of 6- (diethylaminoalkoxy) - 10,11-dihydrodibenzo / b, f / thiepin-10-ol and their maleates | |
| CN114057640A (en) | A kind of asymmetric synthesis method of optically pure (R)/(S)-hydroxychloroquine side chain | |
| CN110172058B (en) | 7-azaspiro [5.6] dodecane-10-one compound and preparation method and application thereof | |
| FI57400C (en) | PROCEDURE FOR FRAMSTAELLNING AV 2,4-DIAMINO-5-BENZYLPYRIMIDINE | |
| CA1125762A (en) | Dihydronicotinic acid derivatives and process for the preparation thereof | |
| US4904688A (en) | Tricyclic amine derivatives | |
| US4847403A (en) | 2-Isopropyl-2-(2-methylphenyl)-5-(N-methyl-N-homoveratrylamino)-valeronitrile and method for producing same | |
| GB2100261A (en) | Aminophenylalkylamine derivatives, a process for their preparation and their use as pharmaceuticals | |
| DE69509510T2 (en) | 2- (AMINOALKOXY) PHENYLALKYLAMINE WITH INFLAMMATORY PROPERTIES | |
| US5698580A (en) | Antiviral agent containing benzodithiin derivative as active ingredient | |
| US5037828A (en) | Piperazine derivatives, uses thereof and pharmaceutical compositions containing them | |
| CN118126029A (en) | Preparation method of piribedil | |
| CS236147B1 (en) | 1- [5-Chloro-2- (2-methylpiperazine methylphenylthio) benzo] - and its maleate | |
| IE67059B1 (en) | A process for the preparation of a 1,4-dihydropyridine derivative namely (-)-2-{[2-(aminoethoxy)ethoxy]methyl}-4-(2,3-dichlorophenyl)-3-ethoxy-carbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine and its salts |